G21® announces the launch of SpaceFlex Trials kit: SpaceFlex r-evolution™

[ad_1]

A breath of innovation: SpaceFlex r-evolution™

G21® S.r.l., – the leading medical device manufacturer, is proud to announce the completion of its line of custom-modular spacers with the arrival of the new trials kit line: SpaceFlex r-evolution.™.

“The year 2021 represents an even more significant year for G21 also from a symbolic point of view: the assonance with our logo that encompasses the achievements of 12 years of important work. We are therefore pleased to welcome this year and present our exclusive trials in this press release.

With the SpaceFlex system and our complete line of cements, we offer the only modular mold system currently available on the market for the treatment of joint infections in orthopaedics. Trials have further enhanced our exclusive modularity studied on the patient’s anatomy in order to perform guided and intuitive surgeries. Furthermore, we have optimized size selection so as to ensure proper congruence and filling, by minimizing the risk of dislocation and migration of the implant with the aid of targeted size selection”says Filippo Foroni, Executive Vice President of G21® S.r.l.

About G21 ® S.r. l

G21 ® S.r.l. offers a range of products for both orthopedics and minimally invasive spine surgery. G21 ® S.r.l. provides bone cement for orthopedics with different levels of viscosity for the making of temporary prothesis for the treatment of infections and septic revisions. G21 ® S.r.l. supplies bone cement for vertebral consolidation for the performing of minimally invasive spine surgeries such as vertebroplasty and kyphoplasty procedures.

From February 2021 the product is officially available on the market.

The company’ s website for new releases and further information is http://www.g-21.it

Contact Reference

Mr. Filippo Foroni

Executive Vice President of G21 S.r.l.

Share article on social media or email:

[ad_2]

Leave a Reply